Limited Competition: Building Partnerships and Broadening Perspectives to Advance Ethical, Legal, and Social Implications (ELSI) Research (BBAER) Program (UM1), Clinical Trial Optional
ID: 355317Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Award Range

$0 - $850K

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/355317

Additional Information

http://grants.nih.gov/grants/guide/rfa-files/RFA-HG-24-026.html
Timeline
    Description

    The National Institutes of Health (NIH) is offering a funding opportunity titled "Limited Competition: Building Partnerships and Broadening Perspectives to Advance Ethical, Legal, and Social Implications (ELSI) Research (BBAER) Program (UM1)," which aims to enhance transdisciplinary ELSI research by engaging underrepresented organizations in the U.S. that have received less than $30 million in NIH funding over the past three fiscal years. The program seeks to foster diverse perspectives in ELSI research, build community partnerships, enhance research capacity, and develop the ELSI workforce, with a focus on timely and complex topics such as equity and justice in genomics. NIH anticipates awarding up to $4.8 million across four grants, with each project lasting up to five years, and applications are due by August 2, 2026. For further inquiries, interested applicants can contact NIH Grants Information at grantsinfo@nih.gov.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    RFA-HG-24-026-Full-Announcement.html
    RFA-HG-24-026.html
    The Department of Health and Human Services, through the National Human Genome Research Institute (NHGRI), is announcing a funding opportunity titled "Building Partnerships and Broadening Perspectives to Advance Ethical, Legal, and Social Implications (ELSI) Research Program (BBAER)." This program aims to enhance transdisciplinary ELSI research by engaging underrepresented organizations in the U.S. that have received less than $30 million in NIH funding over the last three fiscal years. The initiative supports several goals: fostering diverse perspectives in ELSI research, building community partnerships, enhancing research capacity, and developing the ELSI workforce. Key components of the application include establishing a strategic vision, conducting transdisciplinary research, and actively involving relevant communities in research teams. Applications must align with specified research areas, such as equity and justice in genomics or the implications of genetics on identity. The program anticipates awarding up to $4.8 million across four grants with a project period of five years. Eligible applicants must adhere to specific submission requirements and timelines, emphasizing the importance of collaboration and data sharing in advancing the field of genomics and ELSI research. This opportunity reinforces the federal commitment to ensuring diverse input in genomic research while addressing its societal impacts.
    Similar Opportunities
    Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a Notice of Funding Opportunity (NOFO) inviting research proposals focused on the Ethical, Legal, and Social Implications (ELSI) of human genetics and genomics. This initiative aims to encourage multidisciplinary research that explores various methods to address emerging ELSI questions, particularly in relation to health disparities and the implications of genomic data sharing. The NIH emphasizes the importance of including diverse perspectives in research, requiring a Plan for Enhancing Diverse Perspectives (PEDP) as part of the application, which will be evaluated during the review process. Interested applicants, including higher education institutions and community-based organizations, can submit proposals starting January 19, 2024, with a closing date for applications set for November 18, 2026. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced the "Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)" to support research that investigates the ethical, legal, and social implications of human genetics and genomics. This grant encourages applications that utilize a variety of research methods, including empirical qualitative and quantitative approaches, to address significant ELSI issues arising from advancements in genomic technologies. The initiative aims to foster community engagement, particularly with historically underserved populations in genomic research, reflecting a commitment to ethical considerations in scientific progress. Grants of up to $275,000 are available for projects spanning two to three years, with application deadlines starting January 19, 2024, and funding decisions expected by July 2024. For further inquiries, interested applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03), aimed at funding small-scale research projects that investigate the ethical, legal, and social dimensions of human genetics and genomics. This funding opportunity encourages innovative research that addresses the complexities and emerging questions associated with genomic advancements, particularly focusing on diverse populations and potential inequities in access and benefits. Eligible applicants include a wide range of entities such as higher education institutions, non-profits, and government agencies, with funding of up to $50,000 available per year for a maximum of two years. Applications will be accepted starting January 19, 2024, with various submission deadlines through 2026, and interested parties can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Investigator-Initiated Research in Genomics and Health Equity (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Investigator-Initiated Research in Genomics and Health Equity" (RFA-HG-23-017), aimed at promoting health equity through innovative genomic research. This initiative encourages applicants to propose research that enhances the understanding and application of genomics across diverse U.S. populations, with a particular focus on engaging underrepresented groups and incorporating a Plan for Enhancing Diverse Perspectives (PEDP). The NIH plans to commit significant funds, with a maximum budget of $500,000 in direct costs per year for projects lasting four to five years, and applications are due by July 8, 2025. Interested applicants can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries and are encouraged to review the full announcement at NIH Grants.
    Investigator-Initiated Research in Genomics and Health Equity (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Investigator-Initiated Research in Genomics and Health Equity (R21 Clinical Trial Optional)" aimed at supporting small-scale research projects that enhance health equity through genomic research. The initiative seeks to develop innovative approaches and metrics to ensure the equitable application of genomics in improving health outcomes for U.S. populations, particularly focusing on historically underrepresented groups in biomedical research. Eligible applicants include a wide range of organizations, such as higher education institutions, nonprofit organizations, and state governments, with funding available up to $200,000 annually for a maximum of two years. Interested parties should submit their applications by July 8, 2025, and can direct inquiries to NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage for more details at https://grants.nih.gov/grants/guide/rfa-files/RFA-HG-23-018.html.
    Advancing Genomic Medicine Research (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Advancing Genomic Medicine Research (R21 Clinical Trial Optional)" aimed at stimulating innovation in the application of genomic information in clinical care, particularly for populations experiencing health disparities. The initiative seeks to enhance understanding of how to effectively implement and share genomic technologies across diverse communities, including racial and ethnic minorities, underserved rural populations, and sexual and gender minority groups. With an expected total funding of approximately $1.5 million for fiscal year 2024, individual project budgets may reach up to $250,000. Interested applicants must submit their proposals by February 11, 2025, and can find additional details and guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    BRAIN Initiative: Research on the Ethical Implications of Advancements in Neurotechnology and Brain Science (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "BRAIN Initiative: Research on the Ethical Implications of Advancements in Neurotechnology and Brain Science (R01 Clinical Trial Optional)" aimed at exploring the ethical dimensions of neuroscience research. This initiative encourages multidisciplinary teams to address core ethical issues such as informed consent, data privacy, and health disparities, emphasizing the importance of inclusive research practices. Funding is available for both exploratory projects under R21 and larger research grants under R01, with an anticipated budget of $3 million per year for up to eight awards. Interested applicants must submit their proposals by October 9, 2026, and are required to include a Plan for Enhancing Diverse Perspectives (PEDP) to integrate diverse viewpoints in their research. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering funding through the Exploratory/Developmental Bioengineering Research Grants (EBRG) program, aimed at enhancing biomedical research and clinical care. This initiative encourages innovative applications that focus on developing new capabilities to address challenges in biomedical, preclinical, or clinical settings, with an emphasis on feasibility testing and novel methodologies. The program is particularly significant for advancing cancer research through innovative bioengineering approaches, welcoming proposals from a diverse range of eligible applicants, including universities, nonprofits, and small businesses, especially those representing underrepresented groups. The maximum budget for applicants is $275,000 over two years, with applications due by January 7, 2028. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/pa-files/PAR-25-321.html.
    BRAIN Initiative: Research on the Ethical Implications of Advancements in Neurotechnology and Brain Science (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity under the BRAIN Initiative for research on the ethical implications of advancements in neurotechnology and brain science, designated as R21 Clinical Trial Optional grants. This initiative invites multi-disciplinary teams to explore critical ethical issues related to brain research, including topics such as brain imaging, data privacy, and informed consent, with the aim of fostering diverse collaborations and addressing significant ethical challenges in the field. The total funding available is $2 million annually over three years, supporting up to eight new awards, with individual project budgets capped at $275,000 for a two-year period. Interested applicants should note that the application period opens on September 11, 2024, and closes on October 9, 2026; for further inquiries, they can contact NIH Grants Information at grantsinfo@nih.gov.
    Supporting Talented Early Career Researchers in Genomics (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Supporting Talented Early Career Researchers in Genomics," aimed at supporting innovative research projects led by Early Stage Investigators (ESIs) with a focus on genomics. This initiative encourages diverse applicants to propose research that aligns with the mission of the National Human Genome Research Institute (NHGRI), covering areas such as genomic sciences, genomic medicine, genomic data science, and the ethical implications of genomics. The program has a funding commitment of at least $2 million, with plans to award 3-5 grants, each with an annual budget cap of $400,000. Applications must be submitted electronically by February 26, 2027, and should include a detailed professional development plan and a resource sharing plan in compliance with NIH policies. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.